The ataxia-telangiectasia gene product may modulate DNA turnover and control cell fate by regulating cellular redox in lymphocytes. [electronic resource]
Producer: 20010614Description: 1132-8 p. digitalISSN:- 0892-6638
- Acetylcysteine -- chemistry
- Animals
- Anti-Inflammatory Agents -- pharmacology
- Ataxia Telangiectasia -- genetics
- Ataxia Telangiectasia Mutated Proteins
- Cell Cycle -- drug effects
- Cell Cycle Proteins
- Cells, Cultured
- DNA -- genetics
- DNA-Binding Proteins
- Dexamethasone -- pharmacology
- Female
- Flow Cytometry
- Free Radical Scavengers -- chemistry
- Humans
- Immunosuppressive Agents -- pharmacology
- Lymphocytes -- cytology
- Male
- Mice
- Mitogens -- pharmacology
- Oxidation-Reduction
- Phosphatidylinositol 3-Kinases -- genetics
- Protein Serine-Threonine Kinases -- genetics
- Spleen -- cytology
- Tacrolimus -- pharmacology
- Thymidine -- genetics
- Thymus Gland -- cytology
- Tumor Suppressor Proteins
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.